NAMs Atlas
Companies
Organ-on-chip & MPSconfirmed

Vivodyne

Penn spinout that grows 20+ human tissue types on a robotic platform and trains AI models on the results.

Notable

Opened a robotic lab in South San Francisco after the Series A (reported).

Related deals

  • May 29, 2025
    Venture financing, Series A
    Series A to scale robotic human tissue testing as pharma demand rose after the FDA roadmap.
    $40M
    axios.com(opens in new tab)
  • Nov 22, 2023
    Venture financing, Seed
    Seed round to build a robotic, AI-driven platform that tests drugs on lab-grown human tissues.
    $38M
    endpts.com(opens in new tab)

Related updates